New York · 2025-2026 session

A 6927 changesRelates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Precomputed change summary for the public. Sign in for the Diff Viewer (word-level redline, evidence, annotations, and exports).